...
首页> 外文期刊>American Journal of Physiology >Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages
【24h】

Pulmonary surfactant protein A and surfactant lipids upregulate IRAK-M, a negative regulator of TLR-mediated inflammation in human macrophages

机译:肺表面活性物质蛋白A和表面活性剂脂质上调IRAK-M,IRAK-M是人类巨噬细胞中TLR介导的炎症的负调节剂

获取原文
获取原文并翻译 | 示例

摘要

Alveolar macrophages (AMs) are exposed to frequent challenges from inhaled particulates and microbes and function as a first line of defense with a highly regulated immune response because of their unique biology as prototypic alternatively activated macrophages. Lung collectins, particularly surfactant protein A (SP-A), contribute to this activation state by fine-tuning the macrophage inflammatory response. During short-term (10 min-2 h) exposure, SP-A's regulation of human macrophage responses occurs through decreased activity of kinases required for proinflammatory cytokine production. However, AMs are continuously exposed to surfactant, and the biochemical pathways underlying long-term reduction of proinflammatory cytokine activity are not known. We investigated the molecular mechanism(s) underlying SP-A- and surfactant lipid-mediated suppression of proinflammatory cytokine production in response to Toll-like receptor (TLR) 4 (TLR4) activation over longer time periods. We found that exposure of human macrophages to SP-A for 6-24 h upregulates expression of IL-1 receptor-associated kinase M (IRAK-M), a negative regulator of TLR-mediated NF-kappaB activation. Exposure to Survanta, a natural bovine lung extract lacking SP-A, also enhances IRAK-M expression, but at lower magnitude and for a shorter duration than SP-A. Surfactant-mediated upregulation of IRAK-M in macrophages suppresses TLR4-mediated TNF-alpha and IL-6 production in response to LPS, and IRAK-M knockdown by small interfering RNA reverses this suppression. In contrast to TNF-a and IL-6, the surfactant components upregulate LPS-mediated immuno-regulatory IL-10 production, an effect reversed by IRAK-M knockdown. In conclusion, these data identify an important signaling regulator in human macrophages that is used by surfactant to control the long-term alveolar inflammatory response, i.e., enhanced IRAK-M activity.
机译:肺泡巨噬细胞(AMs)经常遭受吸入颗粒物和微生物的挑战,由于其独特的生物学作为原型或活化巨噬细胞,因此具有高度调节的免疫反应,是第一道防线。肺集合蛋白,特别是表面活性剂蛋白A(SP-A),通过微调巨噬细胞的炎症反应来促进这种活化状态。在短期(10分钟至2小时)接触中,SP-A对人类巨噬细胞反应的调节是通过降低促炎细胞因子产生所需激酶的活性来实现的。然而,AMs持续暴露于表面活性剂中,促炎症细胞因子活性长期降低的生化途径尚不清楚。我们调查了响应较长时间的Toll样受体(TLR)4(TLR4)激活的SP-A和表面活性剂脂质介导的促炎细胞因子生成抑制的分子机制。我们发现人类巨噬细胞暴露于SP-A 6-24小时会上调IL-1受体相关激酶M(IRAK-M)的表达,IL-1受体相关激酶M是TLR介导的NF-kappaB激活的负调节剂。暴露于Survanta(一种缺乏SP-A的天然牛肺提取物)也可以增强IRAK-M的表达,但其强度和持续时间均比SP-A短。表面活性剂介导的巨噬细胞IRAK-M的上调抑制了响应LPS的TLR4介导的TNF-α和IL-6的产生,而IRAK-M的小干扰RNA敲低则逆转了这种抑制作用。与TNF-a和IL-6相比,表面活性剂成分上调LPS介导的免疫调节IL-10的产生,这种作用被IRAK-M抑制逆转。总之,这些数据确定了人类巨噬细胞中的重要信号调节剂,表面活性剂可利用该信号调节剂来控制长期肺泡炎症反应,即增强IRAK-M活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号